NCT04250883View on ClinicalTrials.gov

Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study.

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

December 9, 2021

Study Completion Date

March 7, 2022

Conditions
Quality of LifePostoperative ComplicationsAcute PainImmune System Tolerance
Interventions
OTHER

Low intra-abdominal pressure

8 mmHg

OTHER

Deep neuromuscular blockade (NMB)

Deep NMB (PTC1-2)

OTHER

Standard intra-abdominal pressure

14 mmHg

OTHER

Moderate neuromuscular blockade (NMB)

Moderate NMB (TOF 1-2)

Trial Locations (1)

Unknown

Canisius Wilhelmina ziekenhuis, Nijmegen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT04250883 - Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study. | Biotech Hunter | Biotech Hunter